No Data
No Data
Allmed Medical Products (002950.SZ): has repurchased 1.977% of the shares.
Allmed Medical Products (002950.SZ) announced on July 1 that as of June 30, 2024, it has repurchased 12,520,110 shares of the company through the Shenzhen Stock Exchange trading system by centralized bidding, accounting for 1.9771% of the total share capital of the company. The highest fill price was 8.49 yuan/share, the lowest fill price was 7.04 yuan/share, and the total amount paid was 97.8839 million yuan (excluding stamp duty, transaction commission and other transaction costs).
Allmed Medical Products (002950.SZ): A total of 1.062 billion yuan in cash dividends has been distributed since listing.
Allmed medical products (002950.SZ) stated on their investor platform on June 19th that the company has always adhered to the operation in accordance with the law, has a sound internal control system, and the board of directors, supervisors and external audit institutions are diligent and responsible. There is no relevant situation as mentioned by you. The company values shareholder returns and recently completed the profit distribution of 2023. Since the company went public, it has distributed a total of 1.062 billion yuan in cash dividends, which is about 2.21 times the net amount of funds raised. The secondary market price is affected by various factors, and the company's operation is currently normal.
[BT Financial Report Analysis] Allmed Medical Products Q1 2024 financial report: Comprehensive analysis of assets, profits, and cash flow.
Allmed Medical Products (stock code: 002950) is a medical device company specializing in medical dressings and is committed to providing high-quality products for wound care. As a segmented market in the medical device industry, medical dressings are characterized by low value and high frequency of use and are primarily used for wound coverage and infection prevention to facilitate wound healing. With the growing global population aging and increasing chronic diseases, there is a continuous growth in demand for wound care. According to market research data, the global wound management market is expected to grow from USD 13 billion in 2017 to USD 17.8 billion in 2024, with a compound annual growth rate of 4.6%. In addition, patients require faster wound healing and greater comfort.
Allmed Medical Products (002950.SZ) 2023 annual equity distribution: 0.270508 yuan per 10 shares. June 18 is the record date.
Allmed Medical Products (002950.SZ) announced that the company's annual equity distribution plan for 2023 is: based on the current...
Are Allmed Medical Products Co.,Ltd's (SZSE:002950) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Allmed Medical ProductsLtd (SZSE:002950) has had a rough month with its share price down 13%. We, however decided to study the company's financials to determine if they have got anything to do with
Allmed Medical Products (002950.SZ): has repurchased 1.948% of its shares.
Allmed medical products (002950.SZ) announced on June 3rd that as of May 31, 2024, the company has repurchased 12,338,110 shares through the Shenzhen Stock Exchange trading system by centralized competitive transaction mode, accounting for 1.9483% of the total share capital of the company. The highest fill price was 8.49 yuan/share, the lowest fill price was 7.04 yuan/share, and the total amount paid was 96,439,200 yuan (excluding transaction fees such as stamp duty and commission).
No Data